4
Changes in Ownership
Neurogene Inc. Filed Acc 0001606302-26-000007
Chief Executive Officer acquired 756 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
McMinn Rachel · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-22 | Exercise or conversion : show line 1 in the form | +756 | $25.32 | $19,142 | 1,345,063 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-22 | Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) | −756 | 0 | D |
Loading xslF345X06/wk-form4_1790966949.xml…